Skip to main content
. 2018 Jun 20;33:94–104. doi: 10.1016/j.ebiom.2018.06.010

Fig. 3.

Fig. 3

COO and immune characteristics. (a) List of genes included in the pro-inflammatory or the anti-inflammatory gene signatures used in our analysis. (b) Expression of immune gene signatures. P values are calculated between the GCB and the ABC subgroups. “*” indicates p < 0.05. (c) Expression of selected potential immunotherapy targets. Note that CD274 codes for PD-L1 and TNFRSF4 codes for OX40. P values are calculated between the GCB and the ABC subgroups. “*” indicates p < 0.05.